• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Ingersoll Rand Inc. filed SEC Form 8-K: Regulation FD Disclosure

    6/10/24 5:06:24 PM ET
    $IR
    Industrial Machinery/Components
    Industrials
    Get the next $IR alert in real time by email
    false000169915000016991502024-06-102024-06-10

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM 8-K

    CURRENT REPORT
    PURSUANT TO SECTION 13 OR 15(D)
    OF THE SECURITIES EXCHANGE ACT OF 1934

    Date of report (Date of earliest event reported): June 10, 2024

    Ingersoll Rand Inc.

    (Exact Name of Registrant as Specified in Its Charter)


    Delaware
    001-38095
    46-2393770
    (State or Other Jurisdiction of Incorporation)
    (Commission File Number)
    (IRS Employer Identification No.)


    525 Harbour Place Drive, Suite 600
    Davidson, North Carolina 28036
    (704) 655-4000
    (Address, including zip code, of principal executive offices and registrant’s telephone number, including area code)

    N/A
    (Former Name or Former Address, if Changed Since Last Report)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class
    Trading Symbol(s)
    Name of each exchange on which registered
    Common Stock, par value $0.01 per share
    IR
    New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging Growth Company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



    Item 7.01.
    Regulation FD Disclosure.

    Ingersoll Rand Divests Legacy Asbestos Liabilities

    On June 10, 2024, Ingersoll Rand Inc. (“Ingersoll Rand” or the “Company”) permanently divested all of its legacy asbestos liability by selling its wholly-owned subsidiaries that hold these liabilities and the related insurance assets. The sale was made to Delticus, a leading, institutionally capitalized corporate liability acquisition platform that specializes in acquiring and managing long-tail legacy corporate liabilities. Delticus is owned by entities affiliated with Third Point LLC.

    At closing, the divested entities were capitalized with a total of $188.5 million, including $143.5 million from insurance settlement proceeds, $35 million from affiliates of Delticus, and $10 million from Ingersoll Rand. In connection with the sale, Ingersoll Rand and its board of directors received a solvency opinion from an independent advisory firm that formed the basis (along with other inputs) for its determination that the divested entities were solvent and adequately capitalized immediately prior to, at the time of, and after giving effect to, the sale.

    As a result of the transaction, no asbestos liabilities or related insurance assets will be included in Ingersoll Rand’s consolidated year-end 2024 balance sheet. Delticus assumes management of the divested subsidiaries, including the management of their claims and insurance policy reimbursements.

    The Company is pleased to complete this transaction with Delticus, an entity experienced in managing legacy liabilities, and believes that the sale provides greater long-term financial certainty for the Company’s investors and enables the Company to continue to focus on organic and inorganic investments to advance its capabilities and expand its addressable markets, while ensuring responsible stewardship of the legacy asbestos liability.

    Evercore acted as exclusive financial advisor to Ingersoll Rand in connection with the transaction, and Simpson Thacher & Bartlett LLP acted as legal counsel. PJT Partners acted as exclusive financial advisor to affiliates of Delticus in connection with the transaction, and King & Spalding LLP acted as legal counsel.

    The information furnished under this Item 7.01 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that section and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended or the Exchange Act, except as otherwise expressly stated by specific reference in any such filing.


    Forward-Looking Statements

    This Current Report on Form 8-K contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to Ingersoll Rand’s expectations regarding the performance of its business, its financial results, its liquidity and capital resources, its divestiture of all of its legacy asbestos liability and other non-historical statements. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “forecast,” “outlook,” “target,” “endeavor,” “seek,” “predict,” “intend,” “strategy,” “plan,” “may,” “could,” “should,” “will,” “would,” “will be,” “on track to” “will continue,” “will likely result,” or the negative thereof or variations thereon or similar terminology generally intended to identify forward-looking statements. All statements other than historical facts are forward-looking statements.

    These forward-looking statements are based on Ingersoll Rand’s current expectations and are subject to risks and uncertainties, which may cause actual results to differ materially from these current expectations. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. The inclusion of such statements should not be regarded as a representation that such plans, estimates or expectations will be achieved. Important factors that could cause actual results to differ materially from such plans, estimates or expectations include, among others, (1) adverse impact on the Company’s operations and financial performance due to natural disaster, catastrophe, global pandemics, geopolitical tensions, cyber events, or other events outside of the Company’s control; (2) unexpected costs, charges or expenses resulting from completed and proposed business combinations; (3) uncertainty of the expected financial performance of the Company; (4) failure to realize the anticipated benefits of completed and proposed business combinations; (5) the ability of the Company to implement its business strategy; (6) difficulties and delays in achieving revenue and cost synergies; (7) inability of the Company to retain and hire key personnel; (8) evolving legal, regulatory and tax regimes; (9) changes in general economic and/or industry specific conditions; (10) actions by third parties, including government agencies; and (11) other risk factors detailed in Ingersoll Rand’s most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”), as such factors may be updated from time to time in its periodic filings with the SEC, which are available on the SEC’s website at http://www.sec.gov. The foregoing list of important factors is not exclusive.

    Any forward-looking statements speak only as of the date of this Current Report on Form 8-K. Ingersoll Rand undertakes no obligation to update any forward-looking statements, whether as a result of new information or developments, future events or otherwise, except as required by law. Readers are cautioned not to place undue reliance on any of these forward-looking statements.


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     
    INGERSOLL RAND INC.
         
     
     By:
    /s/ Andrew Schiesl
       
    Name: Andrew Schiesl
       
    Title: Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary
         
    Date: June 10, 2024
       



    Get the next $IR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IR

    DatePrice TargetRatingAnalyst
    7/14/2025$93.00Buy → Hold
    Melius
    11/18/2024$112.00 → $107.00Buy → Hold
    Stifel
    11/13/2024$102.00 → $124.00Buy
    UBS
    9/6/2024$97.00Equal-Weight
    Morgan Stanley
    6/21/2024$110.00Buy
    Jefferies
    3/12/2024$92.00Neutral
    Exane BNP Paribas
    2/20/2024$81.00 → $89.00Outperform → In-line
    Evercore ISI
    10/24/2023$73.00Hold → Buy
    Stifel
    More analyst ratings

    $IR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Reynal Vicente exercised 900 shares at a strike of $10.61 and sold $90,000 worth of shares (900 units at $100.00) (SEC Form 4)

    4 - Ingersoll Rand Inc. (0001699150) (Issuer)

    2/20/26 6:00:09 PM ET
    $IR
    Industrial Machinery/Components
    Industrials

    Officer Hepding Elizabeth Meloy exercised 18,246 shares at a strike of $49.52 and sold $1,771,869 worth of shares (18,246 units at $97.11) (SEC Form 4)

    4 - Ingersoll Rand Inc. (0001699150) (Issuer)

    2/19/26 6:31:04 PM ET
    $IR
    Industrial Machinery/Components
    Industrials

    Officer Schiesl Andrew R sold $1,764,000 worth of shares (18,000 units at $98.00), decreasing direct ownership by 61% to 11,405 units (SEC Form 4)

    4 - Ingersoll Rand Inc. (0001699150) (Issuer)

    2/19/26 6:31:01 PM ET
    $IR
    Industrial Machinery/Components
    Industrials

    $IR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $IR
    SEC Filings

    View All

    $IR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Ingersoll Rand Reports Fourth Quarter and Full-Year 2025 Results

    Well-positioned for strong operational performance in 2026 Fourth Quarter 2025 Highlights (All comparisons against the fourth quarter of 2024 and results are as reported unless otherwise noted) Strong performance driven by its competitive differentiator - Ingersoll Rand Execution Excellence (IRX): Orders of $1,952 million, up 8% Revenues of $2,091 million, up 10% Net income attributable to Ingersoll Rand Inc. of $266 million, $0.67 per share Adjusted net income attributable to Ingersoll Rand Inc.1 of $382 million, $0.96 per share, up 14% Adjusted EBITDA1 of $580 million, up 9%, with a margin of 27.7% Operating cash flow of $499 million and free cash flow1 of $462 m

    2/12/26 4:10:00 PM ET
    $IR
    Industrial Machinery/Components
    Industrials

    Ingersoll Rand Declares Regular Quarterly Cash Dividend

    DAVIDSON, N.C., Feb. 11, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Ingersoll Rand Inc. (NYSE:IR), a global provider of mission-critical flow creation and life science and industrial solutions, declared today a regular quarterly cash dividend of $0.02 (two cents) per share of common stock payable on March 26, 2026, to stockholders of record on March 4, 2026. About Ingersoll Rand Inc.Ingersoll Rand Inc. (NYSE:IR), driven by an entrepreneurial spirit and ownership mindset, is dedicated to Making Life Better for our employees, customers, shareholders, and planet. Customers lean on us for exceptional performance and durability in mission-critical flow creation and life science and ind

    2/11/26 4:30:00 PM ET
    $IR
    Industrial Machinery/Components
    Industrials

    Ingersoll Rand to Participate in Upcoming Investor Conferences

    DAVIDSON, N.C., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE:IR), a global provider of mission-critical flow creation and life science and industrial solutions, announced that Vik Kini, chief financial officer, will participate in fireside chats at the following upcoming investor conferences: The Barclays Industrial Select Conference on Wednesday, February 18, 2026, at 9:50 a.m. Eastern Time. The Citi Global Industrial Tech and Mobility Conference on Thursday, February 19, 2026, at 8:50 a.m. Eastern Time. A real-time audio webcast of both fireside chats can be accessed via the Events and Presentations section of the Ingersoll Rand Investor Relations website here. A replay

    1/27/26 8:30:00 AM ET
    $IR
    Industrial Machinery/Components
    Industrials

    SEC Form 144 filed by Ingersoll Rand Inc.

    144 - Ingersoll Rand Inc. (0001699150) (Subject)

    2/19/26 1:58:18 PM ET
    $IR
    Industrial Machinery/Components
    Industrials

    SEC Form 10-K filed by Ingersoll Rand Inc.

    10-K - Ingersoll Rand Inc. (0001699150) (Filer)

    2/17/26 4:36:33 PM ET
    $IR
    Industrial Machinery/Components
    Industrials

    SEC Form 144 filed by Ingersoll Rand Inc.

    144 - Ingersoll Rand Inc. (0001699150) (Subject)

    2/17/26 11:22:11 AM ET
    $IR
    Industrial Machinery/Components
    Industrials

    Ingersoll-Rand downgraded by Melius with a new price target

    Melius downgraded Ingersoll-Rand from Buy to Hold and set a new price target of $93.00

    7/14/25 8:40:34 AM ET
    $IR
    Industrial Machinery/Components
    Industrials

    Ingersoll-Rand downgraded by Stifel with a new price target

    Stifel downgraded Ingersoll-Rand from Buy to Hold and set a new price target of $107.00 from $112.00 previously

    11/18/24 7:51:51 AM ET
    $IR
    Industrial Machinery/Components
    Industrials

    UBS resumed coverage on Ingersoll-Rand with a new price target

    UBS resumed coverage of Ingersoll-Rand with a rating of Buy and set a new price target of $124.00 from $102.00 previously

    11/13/24 8:46:43 AM ET
    $IR
    Industrial Machinery/Components
    Industrials

    $IR
    Leadership Updates

    Live Leadership Updates

    View All

    Ingersoll Rand Welcomes Jerome Guillen to Board of Directors

    DAVIDSON, N.C., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE:IR), a global provider of mission-critical flow creation and life sciences and industrial solutions, today announced the appointment of Jerome Guillen to its Board of Directors, effective January 1, 2026. Guillen spent more than two decades in leadership positions in the automotive and transportation industries, most recently as a president at Tesla, Inc. He held functional leadership across engineering, sales, supply chain, and manufacturing, and played a key role in launching the Model S and Semi Truck programs, advancing production efficiency, automation, and sustainable technologies. Prior to Tesla, he held

    12/17/25 8:30:00 AM ET
    $IR
    Industrial Machinery/Components
    Industrials

    Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

    Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company's next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company's Board of Directors, effective immediately. Dr. Hampton most recently served as

    11/20/25 4:15:00 PM ET
    $EXAS
    $IDYA
    $ILMN
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Industrial Machinery/Components

    Ingersoll Rand Welcomes Aurobind Satpathy to Board of Directors

    DAVIDSON, N.C., July 15, 2025 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE:IR), a global provider of mission-critical flow creation and life sciences and industrial solutions, today announced the appointment of Aurobind Satpathy to its Board of Directors, effective immediately. Satpathy currently serves as a senior partner at McKinsey & Company, a global management consulting firm. During his nearly 30-year career with McKinsey & Company, Satpathy led multi-billion-dollar mergers, guided companies through public-to-private transitions, and architected growth strategies that resulted in increases in market capitalization. In addition, Satpathy led global technology-enablement efforts wi

    7/15/25 8:30:00 AM ET
    $IR
    Industrial Machinery/Components
    Industrials

    $IR
    Financials

    Live finance-specific insights

    View All

    Ingersoll Rand Reports Fourth Quarter and Full-Year 2025 Results

    Well-positioned for strong operational performance in 2026 Fourth Quarter 2025 Highlights (All comparisons against the fourth quarter of 2024 and results are as reported unless otherwise noted) Strong performance driven by its competitive differentiator - Ingersoll Rand Execution Excellence (IRX): Orders of $1,952 million, up 8% Revenues of $2,091 million, up 10% Net income attributable to Ingersoll Rand Inc. of $266 million, $0.67 per share Adjusted net income attributable to Ingersoll Rand Inc.1 of $382 million, $0.96 per share, up 14% Adjusted EBITDA1 of $580 million, up 9%, with a margin of 27.7% Operating cash flow of $499 million and free cash flow1 of $462 m

    2/12/26 4:10:00 PM ET
    $IR
    Industrial Machinery/Components
    Industrials

    Ingersoll Rand Declares Regular Quarterly Cash Dividend

    DAVIDSON, N.C., Feb. 11, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Ingersoll Rand Inc. (NYSE:IR), a global provider of mission-critical flow creation and life science and industrial solutions, declared today a regular quarterly cash dividend of $0.02 (two cents) per share of common stock payable on March 26, 2026, to stockholders of record on March 4, 2026. About Ingersoll Rand Inc.Ingersoll Rand Inc. (NYSE:IR), driven by an entrepreneurial spirit and ownership mindset, is dedicated to Making Life Better for our employees, customers, shareholders, and planet. Customers lean on us for exceptional performance and durability in mission-critical flow creation and life science and ind

    2/11/26 4:30:00 PM ET
    $IR
    Industrial Machinery/Components
    Industrials

    Ingersoll Rand Schedules Fourth Quarter 2025 Earnings Release and Conference Call

    DAVIDSON, N.C., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE:IR), a global provider of mission-critical flow creation and life science and industrial solutions, will issue its fourth quarter 2025 earnings release after the market closes on Thursday, February 12, 2026. Ingersoll Rand will also host a live earnings conference call to discuss the fourth quarter results on Friday, February 13, 2026, at 8 a.m. Eastern Time. To participate in the call, please dial +1-888-330-3073, domestically, or +1-646-960-0683, internationally, and use access code 8970061. A real-time audio webcast of the presentation can be accessed via the Events and Presentations section of the Ingersoll R

    1/12/26 4:30:00 PM ET
    $IR
    Industrial Machinery/Components
    Industrials

    $IR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Ingersoll Rand Inc.

    SC 13G/A - Ingersoll Rand Inc. (0001699150) (Subject)

    11/14/24 1:28:32 PM ET
    $IR
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by Ingersoll Rand Inc.

    SC 13G/A - Ingersoll Rand Inc. (0001699150) (Subject)

    11/14/24 1:22:37 PM ET
    $IR
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G filed by Ingersoll Rand Inc.

    SC 13G - Ingersoll Rand Inc. (0001699150) (Subject)

    11/13/24 10:22:19 AM ET
    $IR
    Industrial Machinery/Components
    Industrials